These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 20367225

  • 1. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.
    Clin Infect Dis; 2010 May 01; 50(9):1238-46. PubMed ID: 20367225
    [Abstract] [Full Text] [Related]

  • 2. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.
    Clin Infect Dis; 2008 Aug 15; 47(4):476-84. PubMed ID: 18627249
    [Abstract] [Full Text] [Related]

  • 3. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
    Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.
    Clin Infect Dis; 2009 Jul 15; 49(2):205-12. PubMed ID: 19508165
    [Abstract] [Full Text] [Related]

  • 4. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.
    Lehmann D, Willis J, Moore HC, Giele C, Murphy D, Keil AD, Harrison C, Bayley K, Watson M, Richmond P.
    Clin Infect Dis; 2010 Jun 01; 50(11):1477-86. PubMed ID: 20420501
    [Abstract] [Full Text] [Related]

  • 5. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.
    Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW, Moore MR, CDC Emerging Infections Program Network.
    Clin Infect Dis; 2011 Jul 15; 53(2):137-43. PubMed ID: 21690620
    [Abstract] [Full Text] [Related]

  • 6. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.
    Pediatr Infect Dis J; 2007 Sep 15; 26(9):771-7. PubMed ID: 17721369
    [Abstract] [Full Text] [Related]

  • 7. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R.
    Clin Infect Dis; 2008 Jan 15; 46(2):174-82. PubMed ID: 18171247
    [Abstract] [Full Text] [Related]

  • 8. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health.
    Pediatr Infect Dis J; 2010 Apr 15; 29(4):289-93. PubMed ID: 19935447
    [Abstract] [Full Text] [Related]

  • 9. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.
    Guevara M, Barricarte A, Gil-Setas A, García-Irure JJ, Beristain X, Torroba L, Petit A, Polo Vigas ME, Aguinaga A, Castilla J.
    Clin Microbiol Infect; 2009 Nov 15; 15(11):1013-9. PubMed ID: 19673968
    [Abstract] [Full Text] [Related]

  • 10. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
    Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, Reingold A, Thomas A, Schaffner W, Craig AS, Smith PJ, Beall BW, Whitney CG, Moore MR, Active Bacterial Core Surveillance/Emerging Infections Program Network.
    J Infect Dis; 2010 Jan 01; 201(1):32-41. PubMed ID: 19947881
    [Abstract] [Full Text] [Related]

  • 11. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
    Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W.
    Pediatr Infect Dis J; 2013 Jun 01; 32(6):604-9. PubMed ID: 23348816
    [Abstract] [Full Text] [Related]

  • 12. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG.
    J Infect Dis; 2007 Nov 01; 196(9):1346-54. PubMed ID: 17922399
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007.
    Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, Rolo D, Grau I, Martín R, Liñares J.
    Clin Infect Dis; 2009 Jan 01; 48(1):57-64. PubMed ID: 19035779
    [Abstract] [Full Text] [Related]

  • 14. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ, McIntosh ED, Reinert RR.
    Int J Infect Dis; 2010 Mar 01; 14(3):e197-209. PubMed ID: 19700359
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996.
    O'Brien KL, Shaw J, Weatherholtz R, Reid R, Watt J, Croll J, Dagan R, Parkinson AJ, Santosham M.
    Am J Epidemiol; 2004 Aug 01; 160(3):270-8. PubMed ID: 15258000
    [Abstract] [Full Text] [Related]

  • 16. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
    Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L, Catalan study group of invasive pneumococcal disease.
    J Infect; 2011 Aug 01; 63(2):151-62. PubMed ID: 21679725
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH.
    Pediatr Infect Dis J; 2010 Apr 01; 29(4):294-300. PubMed ID: 19949357
    [Abstract] [Full Text] [Related]

  • 18. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.
    Vaccine; 2013 Dec 16; 31(52):6232-8. PubMed ID: 24176490
    [Abstract] [Full Text] [Related]

  • 19. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.
    Clin Infect Dis; 2008 Oct 15; 47(8):989-96. PubMed ID: 18781875
    [Abstract] [Full Text] [Related]

  • 20. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Feb 15; 57(6):144-8. PubMed ID: 18272956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.